发明名称 METHODS FOR TREATING RETINOPATHY WITH EXTENDED THERAPEUTIC EFFECT
摘要 Methods for treating and preventing retinopathic conditions by administering an anti-VEGF compound to the vitreous chamber of a patient at risk of, or suffering from, the retinopathy.
申请公布号 US2014328835(A1) 申请公布日期 2014.11.06
申请号 US201414306363 申请日期 2014.06.17
申请人 Allergan, Inc. 发明人 Whitcup Scott M.;Weber David A.
分类号 A61K47/34;A61K39/395;A61K9/00;C07K16/22 主分类号 A61K47/34
代理机构 代理人
主权项 1. An ocular implant for treating macular degeneration comprising an active agent and a carrier associated with the active agent, wherein the carrier comprises a 30/10 w/w mixture of hydrophilic end PLGA and hydrophobic end PLGA and wherein the active agent is a compound that acts to inhibit formation of VEGF or inhibits the binding of VEGF to its receptor and wherein the ocular implant is formed by an extrusion method.
地址 Irvine CA US